Companies / Nigeria
Crusade Against Fake Drugs Gathers Momentum
April 2007 | Industry NewsWith BMI believing that Nigeria's drug market remains undervalued considering the size of the population, we examine drug regulator NAFDAC's ongoing efforts in the fight against counterfeit medicines. This illicit trade is a key reason that Nigerian drug expenditure, in a country of 141mn, was only US$218mn in 2006, and is forecast to reach just US$256mn by 2011.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
